Recombinant Human Wnt-3a Surrogate Protein

Artikelnummer: ABB-RP01618SLQ
Artikelname: Recombinant Human Wnt-3a Surrogate Protein
Artikelnummer: ABB-RP01618SLQ
Hersteller Artikelnummer: RP01618SLQ
Alternativnummer: ABB-RP01618SLQ-100UG,ABB-RP01618SLQ-10UG,ABB-RP01618SLQ-20UG,ABB-RP01618SLQ-50UG
Hersteller: ABclonal
Wirt: Human
Kategorie: Proteine/Peptide
Spezies Reaktivität: Human
Alternative Synonym: WNT3A,Protein Wnt-3a,Wnt3a Surrogate
Recombinant Human Wnt-3a Surrogate Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence of Human Wnt-3a Surrogate fused with hFC at the C-terminus.
Konzentration: < 0.01 EU/µg of the protein by LAL method
Molekulargewicht: 67.52 kDa
Tag: C-hFc
Quelle: HEK293 Cells
Reinheit: 95 % as determined by SDS-PAGE, 95% as determined by HPLC.
Formulierung: Lyophilized from sterile 0.22 µm filtered solution in PBS buffer with Trehalose, Glycerol, and Tween80, pH 7.4.
Target-Kategorie: Wnt Surrogate Protein
Application Verdünnung: Lyophilized from sterile 0.22 µm filtered solution in PBS buffer with Trehalose, Glycerol, and Tween80, pH 7.4.
Anwendungsbeschreibung: ResearchArea: Cytokines & Cytokine receptors. Shipping: Dry Ice
Recombinant Human Wnt-3a Surrogate Protein was determined by SDS-PAGE under reducing conditions with Coomassie Blue.
Recombinant Human Wnt-3a Surrogate Protein is greater than 95% as determined by SEC-HPLC.
Measured by its ability to induce Topflash reporter activity in HEK293T human embryonic kidney cells. The ED50for this effect is 7.38-29.54 ng/mL ,corresponding to a specific activity of 3.39*10<,sup>,4<,/sup>,~1.35*10<,sup>,5<,/sup>, units/mg.
Human stomach organoids organoids were cultured with EGF(Cat. RP03287), FGF10(Cat. RP01140), NOG(Cat. RP01237), RSPO1(Cat. RP00071), WNT-3a(Cat. RP01618SLQ).
Mouse large intestinal organoids were cultured with EGF(Cat.RP03287),NOG(Cat. RP01237), RSPO1(Cat. RP00071),WNT-3a(Cat.RP01618SLQ)
Human liver organoids were cultured with EGF(Cat. RP03287), HGF(Cat. RP01602), FGF2(Cat. RP01042), FGF10(Cat. RP01140), NOG(Cat. RP01237), RSPO1(Cat. RP00071), WNT-3a(Cat. RP01618SLQ).
Human kidney organoids were cultured with EGF(Cat. RP03287), FGF2(Cat. RP01042), FGF7(Cat. RP01717), FGF9(Cat. RP01710), FGF10(Cat. RP01140), IGF-(Cat. RP00996), NOG(Cat. RP01237), RSPO1(Cat. RP00071), WNT-3a(Cat. RP01618SLQ). And further, DKK-1(RP01343) was used to induce the establishment of cell polarity.
Human gastric cancer organoid were cultured with EGF(Cat. RP03287), NOG(Cat. RP01237), FGF10(Cat. RP01140), RSPO1(Cat. RP00071), Wnt-3a Surrogate(Cat. RP01618SLQ), A83-01(Cat. RPM0008), Y-27632 dihydrochloride(Cat.RPM0007), Gastrin 1(Cat. RPM0011), AB-27 Supplement(Cat. RPM0047LQ), N-2 Supplement(Cat. RPM0046LQ).
Mouse lung organoids were cultured in Matrigel (Cat. RPM0003) with medium supplemented with EGF (Cat. RP03287), Noggin (Cat. RP01237), RSPO1 (Cat. RP00071), Wnt-3a (Cat. RP01618SLQ), and FGF-10 (Cat. RP01140). After 8 days of culture, the expression of lineage markers, including E-Cadherin (Cat. A20798), AQP5 (Cat. A23292), and CD49F (Cat. A26707), was assessed by ultra-plex immunofluorescence staining.